Company Profiles

driven by the PitchBook Platform

Labcyte

Description

Developer of an acoustic droplet ejection (ADE) technology designed to enhance personalized medicine programs. The company's acoustic droplet ejection (ADE) technology uses acoustic energy to transfer precise amounts of fluids without touching them, which can improve data quality and reliability and focuses on ultrasonic acoustic energy into a fluid sample to eject droplets of liquid from open wells, enabling healthcare industry to streamline DNA/RNA diagnostic testing, optimize drug discovery pipelines and accelerate life science research.

2000

Founded

PRIVATE

Status

51-200

Employees

2ndary - Private

Latest Deal Type

$85.9M

Total Amount Raised

11

Investors

Description

Developer of an acoustic droplet ejection (ADE) technology designed to enhance personalized medicine programs. The company's acoustic droplet ejection (ADE) technology uses acoustic energy to transfer precise amounts of fluids without touching them, which can improve data quality and reliability and focuses on ultrasonic acoustic energy into a fluid sample to eject droplets of liquid from open wells, enabling healthcare industry to streamline DNA/RNA diagnostic testing, optimize drug discovery pipelines and accelerate life science research.

Website:

www.labcyte.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Other Devices and Supplies

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

170 Rose Orchard Way San Jose, CA 95134United States +1 (408) 747-2000
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Labcyte's full profile, request a free trial.

Labcyte Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Labcyte Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Labcyte Investors (11)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Abingworth ManagementVenture CapitalMinority000 0000000 0000
Alloy VenturesVenture CapitalMinority000 0000000 0000
Cross Atlantic VenturesVenture CapitalMinority000 0000000 0000
DBL PartnersVenture CapitalMinority000 0000000 0000
Delphi VenturesVenture CapitalMinority000 0000000 0000
Abingworth Management Venture Capital
Alloy Ventures Venture Capital
Cross Atlantic Ventures Venture Capital
DBL Partners Venture Capital
Delphi Ventures Venture Capital

Labcyte Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Mark Fischer-ColbrieChief Executive Officer, Board Member and President
Tammy CameronChief Financial Officer
Richard EllsonCo-Founder, Chief Technology Officer & Board Member
Jurgen Osing Ph.DManaging Director
Randy MoonDirector, Materials
Mark Fischer-Colbrie Chief Executive Officer, Board Member and President
Tammy Cameron Chief Financial Officer
Richard Ellson Co-Founder, Chief Technology Officer & Board Member
Jurgen Osing Ph.D Managing Director
Randy Moon Director, Materials

Labcyte Board Members (6)

NameRepresentingRoleSinceContact
Info
Craig TaylorAlloy VenturesGeneral Partner & Co-Founder000 0000
Jonathan MacQuitty Ph.DAbingworth ManagementPartner000 0000
Joseph Keegan Ph.DSelfChairman000 0000
Joseph SmithSelfBoard Member000 0000
Mark Fischer-ColbrieLabcyteChief Executive Officer, Board Member and President000 0000
Craig Taylor General Partner & Co-Founder Alloy Ventures
Jonathan MacQuitty Ph.D Partner Abingworth Management
Joseph Keegan Ph.D Chairman Self
Joseph Smith Board Member Self
Mark Fischer-Colbrie Chief Executive Officer, Board Member and President Labcyte
Request full access to PitchBook